USDA-APHIS Determines That Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted And Bred In The United States
Portfolio Pulse from Benzinga Newsdesk
Yield10 Bioscience, Inc. (NASDAQ:YTEN) has received a determination from USDA-APHIS that its genetically engineered Camelina varieties producing omega-3 fatty acids can be planted and bred in the U.S. This development marks a significant step towards commercial-scale production of omega-3 oils for aquafeed and human nutrition markets. The company plans to focus on development programs, building seed inventory, and engaging with potential commercial partners in 2024. Yield10 has also signed a collaboration agreement with Rothamsted and a Letter of Intent with BioMar Group for commercializing the omega-3 Camelina crop.
March 21, 2024 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Yield10 Bioscience's genetically engineered Camelina varieties have been approved by USDA-APHIS for planting in the U.S., facilitating the company's move towards commercial-scale production of omega-3 oils.
The USDA-APHIS's determination is a critical regulatory milestone for Yield10, enabling the company to advance towards commercial-scale production and potentially secure a significant position in the omega-3 oil market. This development is likely to be viewed positively by investors, as it represents progress in the company's product pipeline and potential for future revenue growth through partnerships and commercial sales.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100